1. Home
  2. CNSP vs STRR Comparison

CNSP vs STRR Comparison

Compare CNSP & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNSP
  • STRR
  • Stock Information
  • Founded
  • CNSP 2017
  • STRR 1985
  • Country
  • CNSP United States
  • STRR United States
  • Employees
  • CNSP N/A
  • STRR N/A
  • Industry
  • CNSP Biotechnology: Pharmaceutical Preparations
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CNSP Health Care
  • STRR Health Care
  • Exchange
  • CNSP Nasdaq
  • STRR Nasdaq
  • Market Cap
  • CNSP 6.5M
  • STRR 7.0M
  • IPO Year
  • CNSP 2019
  • STRR N/A
  • Fundamental
  • Price
  • CNSP $0.10
  • STRR $2.29
  • Analyst Decision
  • CNSP Strong Buy
  • STRR
  • Analyst Count
  • CNSP 1
  • STRR 0
  • Target Price
  • CNSP $0.50
  • STRR N/A
  • AVG Volume (30 Days)
  • CNSP 30.2M
  • STRR 25.4K
  • Earning Date
  • CNSP 11-15-2024
  • STRR 11-19-2024
  • Dividend Yield
  • CNSP N/A
  • STRR N/A
  • EPS Growth
  • CNSP N/A
  • STRR N/A
  • EPS
  • CNSP N/A
  • STRR N/A
  • Revenue
  • CNSP N/A
  • STRR $50,375,000.00
  • Revenue This Year
  • CNSP N/A
  • STRR $15.58
  • Revenue Next Year
  • CNSP N/A
  • STRR $36.27
  • P/E Ratio
  • CNSP N/A
  • STRR N/A
  • Revenue Growth
  • CNSP N/A
  • STRR 2.22
  • 52 Week Low
  • CNSP $0.10
  • STRR $2.06
  • 52 Week High
  • CNSP $40.70
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • CNSP 39.58
  • STRR 45.36
  • Support Level
  • CNSP $0.10
  • STRR $2.10
  • Resistance Level
  • CNSP $0.11
  • STRR $2.39
  • Average True Range (ATR)
  • CNSP 0.02
  • STRR 0.12
  • MACD
  • CNSP -0.00
  • STRR 0.04
  • Stochastic Oscillator
  • CNSP 3.02
  • STRR 66.67

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.

Share on Social Networks: